Peseckis S - Search Results

1

Regulation of enzymatic activity by active site fatty acylation. A new role for long chain fatty acid acylation of proteins.

Berthiaume L, Deichaite I, Peseckis S, Resh MD. Berthiaume L, et al. Among authors: peseckis s. J Biol Chem. 1994 Mar 4;269(9):6498-505. J Biol Chem. 1994. PMID: 8120000 Free article.

2

Synthesis and use of iodo-fatty acid analogs.

Berthiaume L, Peseckis SM, Resh MD. Berthiaume L, et al. Among authors: peseckis sm. Methods Enzymol. 1995;250:454-66. doi: 10.1016/0076-6879(95)50090-1. Methods Enzymol. 1995. PMID: 7651171 No abstract available.

3

Fatty acyl transfer by human N-myristyl transferase is dependent upon conserved cysteine and histidine residues.

Peseckis SM, Resh MD. Peseckis SM, et al. J Biol Chem. 1994 Dec 9;269(49):30888-92. J Biol Chem. 1994. PMID: 7983020 Free article.

4

Dual myristylation and palmitylation of Src family member p59fyn affects subcellular localization.

Alland L, Peseckis SM, Atherton RE, Berthiaume L, Resh MD. Alland L, et al. Among authors: peseckis sm. J Biol Chem. 1994 Jun 17;269(24):16701-5. J Biol Chem. 1994. PMID: 8206991 Free article.

5

Iodinated fatty acids as probes for myristate processing and function. Incorporation into pp60v-src.

Peseckis SM, Deichaite I, Resh MD. Peseckis SM, et al. J Biol Chem. 1993 Mar 5;268(7):5107-14. J Biol Chem. 1993. PMID: 8444887 Free article.

6

Novel use of an iodo-myristyl-CoA analog identifies a semialdehyde dehydrogenase in bovine liver.

Deichaite I, Berthiaume L, Peseckis SM, Patton WF, Resh MD. Deichaite I, et al. Among authors: peseckis sm. J Biol Chem. 1993 Jun 25;268(18):13738-47. J Biol Chem. 1993. PMID: 8514806 Free article.

7

First fatty acylated dipeptides to affect muscarinic receptor ligand binding.

Krishnan V, Pham WN, Messer WS Jr, Peseckis SM. Krishnan V, et al. Among authors: peseckis sm. Bioorg Med Chem Lett. 1999 Dec 6;9(23):3363-8. doi: 10.1016/s0960-894x(99)00604-6. Bioorg Med Chem Lett. 1999. PMID: 10612600

8

Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors.

Huang XP, Nagy PI, Williams FE, Peseckis SM, Messer WS Jr. Huang XP, et al. Among authors: peseckis sm. Br J Pharmacol. 1999 Feb;126(3):735-45. doi: 10.1038/sj.bjp.0702301. Br J Pharmacol. 1999. PMID: 10188986 Free PMC article.

9

Pharmacological characterization of human m1 muscarinic acetylcholine receptors with double mutations at the junction of TM VI and the third extracellular domain.

Huang XP, Williams FE, Peseckis SM, Messer WS Jr. Huang XP, et al. Among authors: peseckis sm. J Pharmacol Exp Ther. 1998 Sep;286(3):1129-39. J Pharmacol Exp Ther. 1998. PMID: 9732369

10

Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors.

Messer WS Jr, Rajeswaran WG, Cao Y, Zhang HJ, el-Assadi AA, Dockery C, Liske J, O'Brien J, Williams FE, Huang XP, Wroblewski ME, Nagy PI, Peseckis SM. Messer WS Jr, et al. Among authors: peseckis sm. Pharm Acta Helv. 2000 Mar;74(2-3):135-40. doi: 10.1016/s0031-6865(99)00026-6. Pharm Acta Helv. 2000. PMID: 10812950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page